TRIV-573

N/A

Report date: 2025/06/09 16:50:49

Base Information

Drug NameTRIV-573

Drug Alias NameKLK5/7 + IL-13 bispecific inhibitor (Triveni Bio)TRIV-573

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-13 inhibitorsAnti-Kallikrein-5Anti-Kallikrein-7

TargetsInterleukin-13Kallikrein-5Kallikrein-7

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTriveni Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesTriveni Bio Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A